Whitehawk Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 2.37125
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

1.94 -0.11 (-5.37%)

49.08% Fall from 52W High

227.0K

XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Not Eligible

Affordable Valuation

54.5 / 100

Technically Neutral

40.4 / 100

1Yr Price target upside is 3%

1 analysts

Whitehawk Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Whitehawk Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

49.08% Fall from 52W High

SWOT Analysis

Whitehawk Therapeutics Inc. Live Price Chart